Rheinland invested 148 million US dollars to build a plant and expand the production of sweeteners by 4,000 tons every year!
Layn Natural Ingredients, an expert in plant extracts, announced an investment of US$148 million for infrastructure expansion, promotion of plant extracts and natural sweeteners innovation and R&D, and consolidation of the supply chain.
The investment project includes a new production facility, which is expected to be completed within three years, and will increase the production of 4,000 tons of stevia leaf extract per year.
As the first listed company in the domestic plant extraction industry, Rheinland mainly produces natural sweetener extracts of stevia and Luo Han Guo, sweet tea extracts, and various functional Plant Extracts, such as Centella asiatica and rosemary. Rhein stated that the move is aimed at meeting the growing global demand for natural sweeteners and plant ingredients rich in polyphenols.
At the same time, the company will invest funds to establish innovation centers in Asia, Europe and the United States, provide formulation and R&D support for global manufacturing partners, and promote the discovery of new plant extracts and specific plant compounds. The company also plans to expand its sustainable agronomy innovation program to expand a transparent and traceable supply chain.
2026-10-10
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Unilever's Bold Move: Shifting the Paradigm in Ice Cream Storage
-
The steady growth in the Development Ansaimi, sucralose and steviol glycosides
-
Global Sweetener Innovation Trends
-
Global View of Sweetener Market Size
-
April Chemical Industry Shutdown Wave Arrives: Maintenance Plans Reflect Deep Cost Anxiety Across Enterprises
-
Nouryon Opens New Customer Experience and Innovation Center in Brazil
-
A Cold-Chain Crackdown in Delhi Sends a Much Bigger Message
-
Is Evonik’s Massive Global Expansion of Hydroxyl-Terminated Polybutadiene (HTPB) a Technological Ambition — or a Geopolitical Gamble?
-
Wanhua’s Counter-Cyclical Expansion: A Gamble or a Strategic Move for the Next Cycle?
-
China’s Approval of Pfizer’s GLP-1 Drug Signals a Sharper Obesity Race
Recommend Reading
-
Lotte Chemical Plans Sale of Selected Operations in Malaysia, Indonesia, and the United States
-
Behind Starbucks China’s Ownership Change: The Race for Localization and Efficiency
-
Beiersdorf Launches Eucerin Skincare Brand in Japan
-
Korea’s Petrochemical Pivot: Industry Embraces Historic Restructuring to Slash Overcapacity
-
From Desert Sands to Dining Tables: Arab Food & Beverage Sector Emerges as Investment Powerhouse
-
This Week's PVC Market Rebounds (12.22-26)
-
This Week's Isopropanol Market Prices Remain Stable (12.22-12.26)
-
December China titanium dioxide market rises
-
Cost support strong, anhydrous hydrogen fluoride market remains firm and tends to strengthen (12.22-12.26)
-
This Week's Styrene Market Slightly Increased (12.22-12.26)